The benefit of testing outweighs the risks of not testing for children’s safety with an anthrax vaccine because the children will be protected in an attack and the virus could not spread. Another reason for testing is to be able to collect data. The risks of not having data on the vaccine are that there would be no known dosage for children nor the possible side effects. In an extreme cases an improper dosage could result in death. Likewise, the side effects could cause an allergic reaction which could lead to death. The benefit of testing the vaccine out weighs the risk because the data can be collected in order to further develop the vaccine in order to make it more effective during a bioterrorist
The benefit of testing outweighs the risks of not testing for children’s safety with an anthrax vaccine because the children will be protected in an attack and the virus could not spread. Another reason for testing is to be able to collect data. The risks of not having data on the vaccine are that there would be no known dosage for children nor the possible side effects. In an extreme cases an improper dosage could result in death. Likewise, the side effects could cause an allergic reaction which could lead to death. The benefit of testing the vaccine out weighs the risk because the data can be collected in order to further develop the vaccine in order to make it more effective during a bioterrorist